CSTL
Price
$19.66
Change
-$0.18 (-0.91%)
Updated
Jul 11, 04:59 PM (EDT)
Capitalization
608.02M
30 days until earnings call
NEO
Price
$7.26
Change
-$0.23 (-3.07%)
Updated
Jul 11 closing price
Capitalization
2.01B
17 days until earnings call
Interact to see
Advertisement

CSTL vs NEO

Header iconCSTL vs NEO Comparison
Open Charts CSTL vs NEOBanner chart's image
Castle Biosciences
Price$19.66
Change-$0.18 (-0.91%)
Volume$4.44K
Capitalization608.02M
NeoGenomics
Price$7.26
Change-$0.23 (-3.07%)
Volume$1.04M
Capitalization2.01B
CSTL vs NEO Comparison Chart in %
Loading...
CSTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CSTL vs. NEO commentary
Jul 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSTL is a Hold and NEO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 12, 2025
Stock price -- (CSTL: $19.66 vs. NEO: $7.26)
Brand notoriety: CSTL and NEO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CSTL: 66% vs. NEO: 57%
Market capitalization -- CSTL: $608.02M vs. NEO: $2.01B
CSTL [@Medical Specialties] is valued at $608.02M. NEO’s [@Medical Specialties] market capitalization is $2.01B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSTL’s FA Score shows that 0 FA rating(s) are green whileNEO’s FA Score has 0 green FA rating(s).

  • CSTL’s FA Score: 0 green, 5 red.
  • NEO’s FA Score: 0 green, 5 red.
According to our system of comparison, CSTL is a better buy in the long-term than NEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSTL’s TA Score shows that 5 TA indicator(s) are bullish while NEO’s TA Score has 4 bullish TA indicator(s).

  • CSTL’s TA Score: 5 bullish, 5 bearish.
  • NEO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CSTL and NEO are a good buy in the short-term.

Price Growth

CSTL (@Medical Specialties) experienced а -3.15% price change this week, while NEO (@Medical Specialties) price change was -3.84% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.39%. For the same industry, the average monthly price growth was -0.20%, and the average quarterly price growth was -0.47%.

Reported Earning Dates

CSTL is expected to report earnings on Nov 10, 2025.

NEO is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Medical Specialties (+0.39% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEO($2.01B) has a higher market cap than CSTL($608M). CSTL YTD gains are higher at: -26.229 vs. NEO (-55.947). NEO has higher annual earnings (EBITDA): -17.61M vs. CSTL (-45.02M). NEO has more cash in the bank: 415M vs. CSTL (243M). CSTL has less debt than NEO: CSTL (15.3M) vs NEO (612M). NEO has higher revenues than CSTL: NEO (592M) vs CSTL (220M).
CSTLNEOCSTL / NEO
Capitalization608M2.01B30%
EBITDA-45.02M-17.61M256%
Gain YTD-26.229-55.94747%
P/E RatioN/A49.50-
Revenue220M592M37%
Total Cash243M415M59%
Total Debt15.3M612M3%
FUNDAMENTALS RATINGS
CSTL vs NEO: Fundamental Ratings
CSTL
NEO
OUTLOOK RATING
1..100
2117
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
73
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9093
PRICE GROWTH RATING
1..100
5788
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CSTL's Valuation (67) in the null industry is in the same range as NEO (73) in the Medical Or Nursing Services industry. This means that CSTL’s stock grew similarly to NEO’s over the last 12 months.

CSTL's Profit vs Risk Rating (100) in the null industry is in the same range as NEO (100) in the Medical Or Nursing Services industry. This means that CSTL’s stock grew similarly to NEO’s over the last 12 months.

CSTL's SMR Rating (90) in the null industry is in the same range as NEO (93) in the Medical Or Nursing Services industry. This means that CSTL’s stock grew similarly to NEO’s over the last 12 months.

CSTL's Price Growth Rating (57) in the null industry is in the same range as NEO (88) in the Medical Or Nursing Services industry. This means that CSTL’s stock grew similarly to NEO’s over the last 12 months.

CSTL's P/E Growth Rating (100) in the null industry is in the same range as NEO (100) in the Medical Or Nursing Services industry. This means that CSTL’s stock grew similarly to NEO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CSTLNEO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 10 days ago
85%
Bearish Trend 1 day ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 1 day ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CSTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OIGNX34.61N/A
N/A
Invesco Oppenheimer International Gr R
MEQAX10.58N/A
N/A
American Century International Val A
NUICX30.93N/A
N/A
Nuveen International Dividend Growth C
MELSX16.00N/A
N/A
Morgan Stanley Inst EMkts Ldrs R6
TVIRX80.24-0.46
-0.57%
Thornburg Small/Mid Cap Core R4